The human exosome: An autoantigenic complex of exoribonucleases in myositis and scleroderma

Arthritis Research

Volumn 3, Issue 2, 2001, Pages 102-106

  Brouwer, R ^a   Pruijn, G J M ^a   van Venrooij, W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoantibodies; Autoantigens; Exoribonucleases; Exosome; PM Scl complex

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EXORIBONUCLEASE; RIBOSOME RNA; RNA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; ESCHERICHIA COLI; EXOSOME; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOSITIS; NONHUMAN; POLYMYOSITIS; PROTEIN SYNTHESIS; REVIEW; RIBOSOME; RNA PROCESSING; SACCHAROMYCES CEREVISIAE; SCLERODERMA; SERUM; WESTERN BLOTTING; YEAST;

AUTOANTIGENS; EXORIBONUCLEASES; HUMANS; MULTIENZYME COMPLEXES; POLYMYOSITIS; SCLERODERMA, SYSTEMIC;

EID: 0035080095     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar147     Document Type: Review

References (49)

1. Autoantibodies in the diagnosis of systemic rheumatic diseases
2. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
3. The U1 snRNP complex: An autoantigen in connective tissue diseases. An update
4. Antinuclear antibody with distinct specificity for polymyositis
5. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations
6. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma
7. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl
8. Scleromyositis: A scleroderma/polymyositis overlap syndrome
9. Autoantibody profiles in sera of European myositis patients
10. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups
11. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis
12. Autoantibodies to small nuclear and cytoplasmic ribonucleo-proteins in Japanese patients with inflammatory muscle disease
13. Immunogenetic associations of scleroderma-related antinuclear antibodies
14. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies
15. The PM/Scl antigens
16. Identification of protein components reactive with anti-PM/Scl autoantibodies
17. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes
18. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein
19. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen
20. Identification of an alpha-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25-beta autoantigen using immobilized overlapping synthetic peptides
21. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: A unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex
22. Nucleolar localization of the PM-Scl antigen
23. Structure and function of the nucleolus
24. To be or not to be in the nucleolus
25. Comparative sequence analysis of ribonucleases HII, III, II PH and D
26. The yeast exosome and human PM-Scl are related complexes of 3′→5′ exonucleases
27. The exosome: A conserved eukaryotic RNA processing complex containing multiple 3′→5′ exoribonucleases
28. Rrp6p, the yeast homologue of the human PM-Scl 100-kDa autoantigen, is essential for efficient 5.8 S rRNA 3′ end formation
29. The exosome: A proteasome for RNA?
30. Musing on the structural organization of the exosome complex
31. Nip7p interacts with Nop8p, an essential nucleolar protein required for 60S ribosome biogenesis, and the exosome subunit Rrp43p
32. Ribosome synthesis in Saccharomyces cerevisiae
33. Degradation of ribosomal RNA precursors by the exosome
34. The exosome subunit Rrp43p is required for the efficient maturation of 5.8S, 18S and 25S rRNA
35. The 3′ end of yeast 5.8S rRNA is generated by an exonuclease processing mechanism
36. Functions of the exosome in rRNA, snoRNA and snRNA synthesis
37. Yeast exosome mutants accumulate 3′-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs
38. Precursors to the U3 snoRNA lack snoRNP proteins but are stabilized by La binding
39. A nuclear 3′-5′ exonuclease involved in mRNA degradation interacts with poly(A) polymerase and the hnRNA protein Npl3p
40. Identification of a regulated pathway for nuclear pre-mRNA turnover
41. The 3′ to 5′ degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SK12 DEVH box protein and 3′ to 5′ exonucleases of the exosome complex
42. Mutations synthetically lethal with cep1 target S. cerevisiae kinetochore components
43. Human dis3p, which binds to either GTP- or GDP-Ran, complements Saccharomyces cerevisiae dis3
44. Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: Intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth
45. Three novel components of the human exosome
46. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)
47. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes
48. Analysis of the specificity of anti-PM-Scl autoantibodies
49. Cell death: A trigger of autoimmunity?